Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Photocure ASA ( (PHCUF) ) has provided an announcement.
Photocure ASA has successfully completed its share buyback program, repurchasing 300,000 shares at an average price of NOK 60.41 per share, as initially announced in December 2024. The buyback was conducted over a period from 19 December 2024 to 14 January 2025, with a total transaction value of approximately NOK 18.12 million. This move increases Photocure’s ownership of its own shares to 3,015,122, representing 1.11% of its share capital, potentially enhancing shareholder value and signaling confidence in the company’s market positioning.
More about Photocure ASA
Photocure ASA, known as The Bladder Cancer Company, specializes in providing innovative solutions to improve the lives of bladder cancer patients using their unique technology that enhances the visibility of cancer cells, thereby improving health outcomes globally. The company is headquartered in Oslo, Norway, and is listed on the Oslo Stock Exchange.
YTD Price Performance: -7.52%
Average Trading Volume: 1,008
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $134.9M
For a thorough assessment of PHCUF stock, go to TipRanks’ Stock Analysis page.
